News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Daily News ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention Michael O'Riordan December 13, 2015
News Daily News Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks Michael O'Riordan December 07, 2015
News Daily News Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk Michael O'Riordan December 02, 2015
News Conference News AHA 2015 Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact Todd Neale November 12, 2015
News Conference News AHA 2015 Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding Todd Neale November 10, 2015
News Daily News Endovascular Therapy Beats Thrombolysis for Improving Function After Stroke L.A. McKeown November 03, 2015
News Daily News Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients Yael L. Maxwell October 30, 2015
News Daily News A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM Yael L. Maxwell October 30, 2015
News Daily News ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction Caitlin E. Cox October 28, 2015
News Industry News Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients October 15, 2015
News Conference News TCT 2015 BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR Yael L. Maxwell October 15, 2015
News Conference News TCT 2015 LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients Yael L. Maxwell October 14, 2015
News Daily News No Interplay Between Access Site, Cangrelor Effects in PCI Patients Caitlin E. Cox October 06, 2015
News Daily News Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy L.A. McKeown September 21, 2015
News Daily News RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI Yael L. Maxwell September 18, 2015
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015